Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Healthy Volunteers)”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04445389
What this trial is testing

Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults

Who this might be right for
SARS-CoV-2
Genexine, Inc. 60
Testing effectiveness (Phase 2)UnknownNCT05315362
What this trial is testing

Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine

Who this might be right for
Vaccination; InfectionCOVID-19
Leiden University Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT04750343
What this trial is testing

Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19)

Who this might be right for
COVID-19 (Healthy Volunteers)
SK Bioscience Co., Ltd. 328
Testing effectiveness (Phase 2)Study completedNCT04324606
What this trial is testing

A Candidate COVID-19 Vaccine (COV001)

Who this might be right for
Coronavirus
University of Oxford 1,077
Early research (Phase 1)Study completedNCT04479644
What this trial is testing

Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198

Who this might be right for
COVID-19
Brii Biosciences Limited 17
Early research (Phase 1)Study completedNCT05197179
What this trial is testing

A Bridging Study of FB2001 in Healthy Subjects

Who this might be right for
COVID-19
Frontier Biotechnologies Inc. 40
Post-approval studies (Phase 4)Ended earlyNCT05037266
What this trial is testing

Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen

Who this might be right for
Healthy Volunteers
Centre Hospitalier Universitaire de Saint Etienne 27
Early research (Phase 1)Study completedNCT04429529
What this trial is testing

Safety of TY027, a Treatment for COVID-19, in Humans

Who this might be right for
Coronavirus Disease-2019 (COVID-19)
Tychan Pte Ltd. 32
Early research (Phase 1)Study completedNCT04336410
What this trial is testing

Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers

Who this might be right for
Coronavirus Infection
Inovio Pharmaceuticals 120
Early research (Phase 1)Study completedNCT05656508
What this trial is testing

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Who this might be right for
COVID-19 Vaccine
Laboratorio Pablo Cassara S.R.L. 80
Early research (Phase 1)Ended earlyNCT05740280
What this trial is testing

ICP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects

Who this might be right for
Healthy Volunteers
Cellivery Therapeutics, Inc. 24
Early research (Phase 1)Study completedNCT05208996
What this trial is testing

The siCoV/KK46 Drug Open-safety Study

Who this might be right for
COVID-19
National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia 10
Early research (Phase 1)UnknownNCT04441918
What this trial is testing

Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects

Who this might be right for
COVID-19; and High Infection Risk of SARS-CoV-2
Shanghai Junshi Bioscience Co., Ltd. 40
Early research (Phase 1)Study completedNCT05604690
What this trial is testing

Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers

Who this might be right for
COVID-19
Intravacc B.V. 40
Early research (Phase 1)Study completedNCT05525910
What this trial is testing

Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Biological AvailabilityHealthy Participants
Pfizer 15
Early research (Phase 1)Study completedNCT04564040
What this trial is testing

A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole

Who this might be right for
Mantle Cell LymphomaCOVID-19
AstraZeneca 20
Early research (Phase 1)Study completedNCT04691947
What this trial is testing

Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC

Who this might be right for
COVID-19 Vaccine
Health Institutes of Turkey 44
Early research (Phase 1)Study completedNCT06878170
What this trial is testing

A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers

Who this might be right for
COVID-19
Rock BioMedical, Inc. 60
Early research (Phase 1)Ended earlyNCT04941183
What this trial is testing

Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients

Who this might be right for
Covid19
Neutrolis 52
Early research (Phase 1)Study completedNCT05339334
What this trial is testing

Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.

Who this might be right for
Healthy Participants
Pfizer 14
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation